retatrutide type 2 diabetes phase 2 results 2: Weight Loss and Key Trial Findings – Bolt Pharmacy Retatrutide—A Game Changer in Obesity
Description
Aging Cell (2013) 12(2):292302
It possesses Gly at position 2 instead of Ala 8 in GLP-1, offering outstanding resistance to DPP-IV (Figure 2)
Several studies reported that inappropriate ANGII/AT1R activation occurs because of different mechanisms, particularly in patients with T2DM
Human studies look at the compound in controlled trial designs
